二、考核原则 考核评价必须坚持公正、公开、公平的原则，严格按照本办法和考核对象的 业绩进行评价，以实现激励计划与激励对象工作业绩、贡献紧密结合，从而提高 公司整体业绩，实现公司与全体股东利益最大化。 三、考核范围 本办法适用于参与公司本次限制性股票激励计划的所有激励对象。 四、考核机构 深圳明阳电路科技股份有限公司 2025 年限制性股票激励计划实施考核管理办法 深圳明阳电路科技股份有限公司 深圳明阳电路科技股份有限公司（以下简称"明阳电路"或"公司"）为进 一步加强完善公司法人治理结构，健全长效激励约束机制，吸引和留住专业管理、 核心技术和业务人才，充分调动公司员工积极性和创造性，有效提升核心团队凝 聚力和企业核心竞争力，确保公司战略目标实现及股东利益最大化，公司拟对公 司核心人才进行股权激励，公司制定了《深圳明阳电路科技股份有限公司 2025 年限制性股票激励计划（草案）》（以下简称"激励计划"）。 为保证激励计划的顺利实施，现根据《中华人民共和国公司法》《中华人民 共和国证券法》《上市公司股权激励管理办法》等有关法律法规和规范性文件、 以及《公司章程》的相关规定，并结合公司的实际情况，特制定本办法。 一 ...

证券简称：明阳电路 证券代码：300739 债券简称：明电转债 债券代码：123087 本公司所有激励对象承诺，公司因信息披露文件中有虚假记载、误导性陈述 或者重大遗漏，导致不符合授予权益或行使权益安排的，激励对象应当自相关信 息披露文件被确认存在虚假记载、误导性陈述或者重大遗漏后，将由本激励计划 所获得的全部利益返还公司。 特别提示 债券简称：明电转 02 债券代码：123203 （草案） 深圳明阳电路科技股份有限公司 深圳明阳电路科技股份有限公司 二〇二五年八月 深圳明阳电路科技股份有限公司 2025 年限制性股票激励计划（草案） 声 明 本公司及全体董事、监事保证本激励计划及其摘要不存在虚假记载、误导性 陈述或重大遗漏，并对其真实性、准确性、完整性承担法律责任。 三、参与本激励计划的激励对象不包括公司独立董事、监事。激励对象符合 《上市公司股权激励管理办法》第八条、《深圳证券交易所创业板股票上市规则》 第 8.4.2 条的规定，不存在不得成为激励对象的下列情形： （一）最近 12 个月内被证券交易所认定为不适当人选； （二）最近 12 个月内被中国证监会及其派出机构认定为不适当人选； （三）最近 12 ...

Core Viewpoint - The company has adjusted the exercise prices of stock options under its 2020 stock option and restricted stock incentive plan due to the implementation of its 2024 annual equity distribution, which will not materially affect its financial status and operating results [3][4]. Group 1: Approval Process - The company has followed the necessary approval procedures for the stock option and restricted stock incentive plan, including independent opinions from directors, lawyers, and independent financial advisors [1][2]. - The adjustments to the incentive plan have been approved by the company's board and do not require further shareholder approval [3][4]. Group 2: Adjustment Details - The exercise price for the initially granted stock options has been adjusted to 4.979 yuan per share, while the exercise price for the reserved stock options has been adjusted to 5.479 yuan per share [3][4]. - The adjustment method follows the company's incentive plan regulations, which state that the exercise price should be adjusted in the event of profit distribution or other capital changes [3][4]. Group 3: Impact of Adjustments - The adjustments to the exercise prices will not have a substantial impact on the company's financial condition or operating results [4]. - The adjustments comply with relevant laws and regulations, ensuring that shareholder interests are not harmed [4].

Core Viewpoint - The company has announced that the conditions for the first exercise period of the stock options under the 2024 stock option and restricted stock incentive plan have been met, allowing eligible participants to exercise their options [1][6][17]. Summary by Sections Incentive Plan Overview - The company approved the 2024 stock option and restricted stock incentive plan, granting 4.5 million stock options and 958,000 restricted stocks to up to 98 participants [1]. - The first exercise period for the stock options is set from the first trading day after the completion of the procedures until September 22, 2026 [1]. Exercise Arrangement - The exercise schedule for the stock options is divided into three periods: - First exercise period: 40% from 12 months to 24 months after the grant date - Second exercise period: 40% from 24 months to 36 months after the grant date - Third exercise period: 20% from 36 months to 48 months after the grant date [2]. Approval Process - The plan has undergone necessary approvals and disclosures, including legal opinions from Beijing Jindu (Guangzhou) Law Firm [2][3][5]. Conditions for Exercise - The board confirmed that the conditions for the first exercise period have been met, allowing 1.4408 million stock options to be exercised at an adjusted price of 14.91 yuan per option [6][9][17]. - The exercise conditions include no negative audit opinions and compliance with relevant laws and regulations [9][10]. Impact on Company - If all eligible stock options are exercised, the total share capital will increase by 1.4408 million shares, which may dilute earnings per share and return on equity [15]. - The choice of a self-exercise model will not materially affect the pricing and accounting of the stock options [16]. Legal and Supervisory Opinions - The supervisory board and legal counsel have confirmed that the exercise conditions have been met and that the process complies with legal and regulatory requirements [17][18].

Group 1 - The company has conducted a review of the "2025 Restricted Stock Incentive Plan (Draft)" and confirmed its eligibility to implement the stock incentive plan based on relevant laws and regulations [1][2][3] - The review indicates that the plan's implementation will align the interests of management and shareholders, enhance management efficiency, and contribute to the company's sustainable development without harming the interests of the company and all shareholders [2][3][4] - The plan requires approval from the company's shareholders' meeting before implementation [2][3] Group 2 - The review of the "2025 Restricted Stock Incentive Plan Implementation Assessment Management Measures" confirms that the assessment indicators are scientific, reasonable, comprehensive, and operational, ensuring the smooth implementation of the incentive plan [3][4] - The list of incentive objects includes only formal employees of the company, excluding independent directors, supervisors, foreign employees, and shareholders or actual controllers holding more than 5% of the company's shares [3][4] - The review concludes that the qualifications of the incentive objects meet the requirements set forth in the relevant laws and regulations, making their eligibility for the incentive plan valid [4]

Group 1 - The company, Basestone Pharmaceuticals-B (02616), announced the grant of a total of 4.8 million stock options to 5 option grantees for the subscription of 4.8 million shares as part of its employee shareholding plan post-initial public offering [1] - Additionally, the company granted a total of 1.93 million restricted share units to 5 restricted share unit grantees under its post-initial public offering restricted share award plan, subject to acceptance by the grantees [1]

关于欣旺达电子股份有限公司 限制性股票归属及股票期权行权条件成就、作废 部分第二类限制性股票及注销部分股票期权相关事项的 法 律 意 见 书 中国 深圳 福田区 益田路 6001 号太平金融大厦 11、12 层 邮编：518038 电话：（0755）88265288 传真：（0755）88265537 电子邮箱：info@ sundiallawfirm.com 网站：www. sundiallawfirm.com 法律意见书 广东信达律师事务所 关于欣旺达电子股份有限公司 限制性股票归属及股票期权行权条件成就、作废部分 第二类限制性股票及注销部分股票期权相关事项的 法律意见书 信达励字（2025）第121号 致：欣旺达电子股份有限公司 广东信达律师事务所（以下简称"信达"）接受欣旺达电子股份有限公司（以 下简称"公司"或"欣旺达"）的委托，担任公司2022年限制性股票与股票期权 激励计划项目（以下简称"本次激励计划"）的专项法律顾问。信达律师根据《中 华人民共和国公司法》 《中华人民共和国证券法》及中国证券监督管理委员会（以 下简称"中国证监会"）发布的《上市公司股权激励管理办法》 出具的证明文件或口头及书面 ...

Core Viewpoint - The announcement details the achievement of conditions for the third exercise period of stock options and the second exercise period of reserved grants under the 2022 restricted stock and stock option incentive plan of Xinwangda Electronics Co., Ltd. Summary by Sections Incentive Plan Overview - The 2022 incentive plan includes a total of 25.78 million shares, accounting for approximately 1.50% of the company's total share capital of 1,718.96 million shares at the time of the announcement. The initial grant consists of 24.93 million shares, representing 96.70% of the total plan, while the reserved grant totals 0.85 million shares, or 3.30% of the total plan [1][2]. Stock Options and Restricted Stocks - The company plans to grant 17.19 million stock options, which is 1.00% of the total share capital. The initial grant includes 16.69 million options, accounting for 97.09% of the total stock options, with 0.5 million reserved options [2][3]. Exercise Conditions - The exercise of stock options and restricted stocks is contingent upon meeting specific performance targets and tenure requirements. The first exercise period requires a 30% vesting after 12 months, the second period another 30% after 24 months, and the third period 40% after 36 months [4][5]. Performance Targets - The performance targets for the first exercise period in 2022 require a minimum revenue of 43.2 billion yuan. The targets for subsequent years are yet to be specified [6][7]. Approval Procedures - The company has completed necessary approvals for the incentive plan, including granting 824,000 restricted stocks at a price of 19.60 yuan per share and 1,669,000 stock options at an exercise price of 39.19 yuan per option [8][9]. Adjustments to Grant Prices - The grant price for restricted stocks has been adjusted from 19.60 yuan to 19.53 yuan, and the exercise price for stock options has been adjusted from 39.19 yuan to 39.12 yuan due to the implementation of the company's profit distribution plan [12][20]. Recent Developments - As of August 26, 2025, the company announced the completion of the conditions for the third exercise period and the second exercise period of reserved grants, allowing 689 eligible participants to exercise a total of 4.7428 million stock options [30][31].

Core Viewpoint - The Supervisory Board of Xinwanda Electronics Co., Ltd. has reviewed and approved the eligibility of 1,682 incentive recipients for the third vesting and exercise period of the 2022 restricted stock and stock option incentive plan, confirming compliance with relevant laws and regulations [1][2]. Group 1 - The incentive plan includes 1,682 eligible recipients who meet the qualifications set forth by the Company Law, Securities Law, and other relevant regulations [1]. - The number of restricted stocks to be vested is 1.6561 million shares, while the number of stock options to be exercised is 4.9928 million [2]. - The actions taken do not harm the interests of the company or its shareholders, adhering to all legal and regulatory requirements [2].

Core Viewpoint - Shenzhen Zhenbang Intelligent Technology Co., Ltd. has announced the cancellation of 50,980 stock options, which accounts for 0.035% of the company's total share capital, due to the non-exercise of these options during the third exercise period [1][11]. Summary by Sections Announcement of Stock Option Cancellation - The company held a board meeting on August 26, 2025, where it approved the proposal to cancel stock options that were not exercised during the specified period [1]. - The cancellation involves 50,980 stock options related to 9 incentive recipients [1][11]. Approval Procedures - The relevant approval procedures for the stock option cancellation have been completed, including independent opinions from the board and legal advice [1][11]. - The company has followed the necessary regulations as outlined in the "Management Measures for Equity Incentives of Listed Companies" and the "2021 Incentive Plan" [11]. Impact of Cancellation - The cancellation of stock options will not affect the company's share capital or the distribution of shares among shareholders, ensuring compliance with listing conditions [11]. - The company maintains that this action will not harm the interests of shareholders, particularly minority shareholders [11]. Future Arrangements - The board will proceed with the necessary procedures for the cancellation of stock options as per the regulations of the Shenzhen Stock Exchange and will fulfill information disclosure obligations [11]. Opinions from Committees and Legal Advisors - The board's remuneration and assessment committee has confirmed that the cancellation aligns with regulatory requirements and does not jeopardize the company's ongoing operations [11]. - Legal opinions have been obtained confirming that the necessary approvals for the cancellation have been secured [11].